DIRS.INFO The most relevant business & tech news

☆ Insurance stocks are rallying as a way to play one of the hottest spots for inflation
▼ + stars: | 2024-04-19 | by ( Jesse Pound | In Jesse-Pound | ) www.cnbc.com time to read: +5 min

The stubbornly high inflation readings to start 2024 are good news for one group of stocks — insurance companies. Stocks to watch In general, Wall Street analysts are buying the underlying story for these insurance stocks. For a slightly different angle, Wells Fargo analyst Elyse Greenspan upgraded Hamilton Insurance Group to overweight last week. Potential downsides To be sure, there are several factors that could derail the rally for insurance stocks. Another concern is so-called "social inflation," in which legal trends or regulatory changes can drive costs higher for insurance companies.

Persons: Goldman, Robert Cox, Stocks, Goldman's Cox, Cox, Wells, Elyse Greenspan, Hamilton, HG, Greenspan, Jimmy Bhullar, Andrew McGee, McGee, — CNBC's Michael Bloom Organizations: Bureau of Labor Statistics, Allstate, Wall Street, PGR, Progressive, Hartford Financial Services, Hamilton Insurance Group, U.S . Insurance, JPMorgan, CNBC Locations: Northbrook , Illinois, Wells Fargo

☆ Goldman Sachs analysts have increased conviction in these 5 stocks
▼ + stars: | 2023-11-18 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Investors looking for value heading into the holiday season should look no further than the following stocks, Goldman Sachs says. The company beat on both the top and bottom line to go along with strong guidance for the fourth-quarter. TransDigm- buy rating "TDG reported F4Q23 key metrics above consensus, guided the same ones for FY2024 above consensus, announced a large special dividend & announced a new sizable acquisition. Willis Towers Watson - buy rating "We view 3Q23 results as quite supportive of our thesis around ramping talent production & cost efficiencies & we reiterate our Buy rating as we expect momentum to continue on both top & bottom line results. Trex Company- buy rating "We are also encouraged by mgmt's optimism for further top-line gains in 2024, supporting our forecast for robust FCF to allow for investments in growth opportunities and shareholder returns.

Persons: Goldman Sachs, Goldman, Ross, Willis Towers Watson, Noah Poponak, TransDigm, Poponak, Robert Cox, Willis, Cox, there's, Brett Feldman, Warner's, Feldman, shouldn't Organizations: CNBC, Warner Brothers Discovery, TransDigm, Warner Brothers, 3Q, Trex Locations: TransDigm

☆ Medicamentul care oprește complet răspândirea coronavirusului în 24 de ore
▼ + stars: | 2020-12-15 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +2 min

Experții în sănătate sunt de acord cu privire la faptul că vaccinul ar putea pune punct pandemiei de coronavirus. Este vorba despre MK-4482/EIDD-2801 – Monulpiravir – care ar putea să elimine total răspândirea coronavirusului în doar 24 de ore, potrivit studiului efectuat de Institutul de Științe Biomedicale al Universității de Stat din Georgia. Medicamentul antiviral a fost dezvoltat la Universitatea Emory din Atlanta și a fost inițial conceput pentru a trata gripa și pentru a preveni multiplicarea virusului. Aceste proprietăți au făcut din MK-4482 / EIDD / 2801 un candidat puternic pentru controlul farmacologic al Covid-19”, scrie în raport. Dacă tratamentul se dovedește eficient și în cazul oamenilor, ar însemna că pacienții infectați cu SARS CoV-2 și tratați cu Monulpiravir ar putea deveni neinfecțioși în 24 de ore de la începerea tratamentului.

Persons: Dr . Robert Cox Organizations: Universității de Stat, Nature, Universitatea Emory Locations: Georgia, Atlanta

Search resuls for: "Robert Cox"

3 mentions found